Abiopharma

🔍 Arnold Ken E. (Executive)

Company: AVNET INC (AVT)

Report Date: 2026-08-27

Detailed Transactions and Holdings:

• Acquired 5,111 shares of Common Stock (Direct)
  Date: 2026-08-27 | Code: A | equity_swap_involved: 0 | shares_owned_after: 88,062.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,139 shares of Common Stock at $87.81 per share (Direct)
  Date: 2026-08-27 | Code: F | equity_swap_involved: 0 | shares_owned_after: 85,923.00 | transaction_form_type: 4 | Footnotes: F2, F3
• Holds 7,908 shares of Employee Stock Option (Right to Buy) at $44.12 per share (Derivative)
  Date: 2026-08-27 | Code: H | Expires: 2029-02-17 | shares_owned_after: 7,908.00 | Footnotes: F4
• Holds 12,404 shares of Employee Stock Option (Right to Buy) at $39.72 per share (Derivative)
  Date: 2026-08-27 | Code: H | Expires: 2029-08-12 | shares_owned_after: 12,404.00 | Footnotes: F4
• Holds 33,604 shares of Employee Stock Option (Right to Buy) at $29.85 per share (Derivative)
  Date: 2026-08-27 | Code: H | Expires: 2030-11-15 | shares_owned_after: 33,604.00 | Footnotes: F5
• Holds 31,080 shares of Employee Stock Option (Right to Buy) at $39.62 per share (Derivative)
  Date: 2026-08-27 | Code: H | Expires: 2031-08-22 | shares_owned_after: 31,080.00 | Footnotes: F6

Footnotes:

• F1: Consists of performance stock units earned under long-term incentive plan.
• F2: Surrendered shares to pay taxes on issued shares.
• F3: Includes 37,844 shares earned but not yet vested.
• F4: The Option vests in four equal annual installments beginning on the first anniversary of the date of grant.
• F5: The Option vests in four equal annual installments beginning on the first anniversary of the date of grant.
• F6: The Option vests in four equal installments beginning on the first anniversary of the date of grant.